Please wait while the formulary information is being retrieved.
OMNIPAQUE (IOHEXOL)
- Myelography
- Angiocardiography
- Angiography
- Aortography
- Arteriography
- Cardiac ventriculography
- Cisternography
- Computerized tomography of abdomen
- CT scan of brain
- Digestive system radiography
- Endoscopic retrograde cholangiopancreatography
- Hysterosalpingography
- Myelography
- Urography
- Venography
- Omnipaque Oral Solution
- Omnipaque 350 Intravenous Solution
- Omnipaque 300 Intravenous Solution
- Omnipaque 240 Intravenous Solution
- Omnipaque 180 Intrathecal Solution
- Omnipaque 140 Intravenous Solution
12 mg iodine/mL oral solution
- Dosage information is not available
9 mg iodine/mL oral solution
- Dosage information is not available
350 mg iodine/mL intravenous solution
- Dosage information is not available
300 mg iodine/mL intravenous solution
- Dosage information is not available
240 mg iodine/mL intravenous solution
- Dosage information is not available
180 mg iodine/mL intrathecal solution
- Dosage information is not available
140 mg iodine/mL intravenous solution
- Dosage information is not available
- Actoplus Met
- Actoplus Met Xr
- alogliptin-metformin
- Fortamet
- glipizide-metformin
- Glucophage
- Glucophage Xr
- Glucovance
- Glumetza
- glyburide-metformin
- Janumet
- Janumet Xr
- Jentadueto
- Kazano
- Kombiglyze Xr
- linagliptin-metformin
- metformin
- pioglitazone-metformin
- Prandimet
- repaglinide-metformin
- Riomet
- saxagliptin-metformin
- sitagliptin-metformin
Contraindicated
- Methotrexate (anti-rheumatic)
- methotrexate sodium
- methotrexate sodium (PF)
- Rheumatrex
- Trexall
Severe
Moderate
- None
- None
Contraindicated
- Dehydration
- Hyperthyroidism
- Kidney disease with reduction in GFR
- Pheochromocytoma
- Seizure disorder
- Severe hepatic disease
- Sickle cell disease
Severe
Moderate
- Asthma
- Hypothyroidism
- Waldenstrom's macroglobulinemia
OMNIPAQUE (IOHEXOL)
- Myelography
- Angiocardiography
- Angiography
- Aortography
- Arteriography
- Cardiac ventriculography
- Cisternography
- Computerized tomography of abdomen
- CT scan of brain
- Digestive system radiography
- Endoscopic retrograde cholangiopancreatography
- Hysterosalpingography
- Myelography
- Urography
- Venography
- None
- Acute abdominal pain
- Back pain
- Diarrhea
- Dizziness
- Dysgeusia
- Flatulence
- Headache disorder
- Pain
- Sensation of warmth
- Skin swelling
More Frequent
Severe
Less Severe
- Ventricular premature beats
- Chest pain
- Drowsy
- Nausea
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute generalized exanthematous pustulosis
- Acute renal failure
- Allergic dermatitis
- Anaphylaxis
- Angina
- Angioedema
- Anuria
- Behavioral disorders
- Bradycardia
- Bronchospastic pulmonary disease
- DRESS syndrome
- Dyspnea
- Guillain-barre syndrome
- Hypothyroidism
- Injection site sequelae
- Nasal congestion
- Non-infective meningitis
- Oliguria
- Pulmonary edema
- Seizure disorder
- Severe hypotension
- Skin rash
- Stevens-johnson syndrome
- Toxic epidermal necrolysis
- Urticaria
- Ventricular fibrillation
- Ventricular tachycardia
Less Severe
- Chills
- Depersonalization
- Dysuria
- Eye tearing
- Fever
- Hallucinations
- Hyperhidrosis
- Memory impairment
- Photophobia
- Proteinuria
- Pruritus of skin
- Visual changes
Contraindicated
None
Severe Precaution
Iohexol
Rare risk of hypothyroidism/thyroid suppression. Maintain adequate hydration. Increased risk of adverse effects with asthma or allergy, CHF, serum creatinine > 1.5 mg/dL, or age < 12 months. No safety and efficacy for 350 mg iodine/mL strength.
- 1 Day – 18 Years
- Rare risk of hypothyroidism/thyroid suppression. Maintain adequate hydration. Increased risk of adverse effects with asthma or allergy, CHF, serum creatinine > 1.5 mg/dL, or age < 12 months. No safety and efficacy for 350 mg iodine/mL strength.
Management or Monitoring Precaution
None
Iohexol
- Severity Level:
2
- Additional Notes: Consider maternal diagnostic benefit versus potential fetal adverse effects
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Iohexol
Limited data suggest minimal amount excreted; poor oral absorption
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Limited data suggest minimal amount excreted; poor oral absorption |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Iohexol
General-Elderly are more sensitive to adverse effects. Recommend adequate hydration before and after drug administration.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | Y | N | N | Y |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
Formulary Reference Tool